Search
Regulatory Story
Company GlaxoSmithKline PLC
TIDM GSK
Headline Director/PDMR Shareholding
Released 18:01 24-Jul-2019
Number 6361G18

RNS Number : 6361G
GlaxoSmithKline PLC
24 July 2019
 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Sir Philip Hampton

b)

Position/status

Non-Executive Chairman

 

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

 

b)

Nature of the transaction

Acquisition of notional Ordinary Shares under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2019 to 30 June 2019.

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

£16.54

2,645.103

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

d)

Aggregated information

 

n/a (single transaction)

Aggregated volume Price

 

e)

Date of the transaction

2019-07-24

f)

Place of the transaction

 

n/a

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr Vindi Banga

b)

Position/status

Senior Independent Non-Executive Director

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

 

b)

Nature of the transaction

Acquisition of notional Ordinary Shares under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2019 to 30 June 2019.

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

£16.54

547.914

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

d)

Aggregated information

 

n/a (single transaction)

Aggregated volume Price

 

e)

Date of the transaction

2019-07-24

f)

Place of the transaction

 

n/a

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr Vivienne Cox

b)

Position/status

Independent Non-Executive Director

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

 

b)

Nature of the transaction

Acquisition of notional Ordinary Shares under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2019 to 30 June 2019.

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

£16.54

434.553

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

d)

Aggregated information

 

n/a (single transaction)

Aggregated volume Price

 

e)

Date of the transaction

2019-07-24

f)

Place of the transaction

 

n/a

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Ms Lynn Elsenhans

b)

Position/status

Independent Non-Executive Director

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

American Depositary Shares ('ADSs')

 

ISIN: US37733W1053

 

b)

Nature of the transaction

Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2019 to 30 June 2019.

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

$41.14

1,202.621

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

d)

Aggregated information

 

n/a (single transaction)

Aggregated volume Price

 

e)

Date of the transaction

2019-07-24

f)

Place of the transaction

 

n/a

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr Laurie Glimcher

b)

Position/status

Independent Non-Executive Director

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

American Depositary Shares ('ADSs')

 

ISIN: US37733W1053

 

b)

Nature of the transaction

Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2019 to 30 June 2019.

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

$41.14

1,336.245

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

d)

Aggregated information

 

n/a (single transaction)

Aggregated volume Price

 

e)

Date of the transaction

2019-07-24

f)

Place of the transaction

 

n/a

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr Jesse Goodman

b)

Position/status

Independent Non-Executive Director

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

American Depositary Shares ('ADSs')

 

ISIN: US37733W1053

 

b)

Nature of the transaction

Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2019 to 30 June 2019.

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

$41.14

403.177

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

d)

Aggregated information

 

n/a (single transaction)

Aggregated volume Price

 

e)

Date of the transaction

2019-07-24

f)

Place of the transaction

 

n/a

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Ms Judy Lewent

b)

Position/status

Independent Non-Executive Director

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

American Depositary Shares ('ADSs')

 

ISIN: US37733W1053

 

b)

Nature of the transaction

Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2019 to 30 June 2019.

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

$41.14

449.255

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

d)

Aggregated information

 

n/a (single transaction)

Aggregated volume Price

 

e)

Date of the transaction

2019-07-24

f)

Place of the transaction

 

n/a

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr Urs Rohner

b)

Position/status

Independent Non-Executive Director

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

 

b)

Nature of the transaction

Acquisition of notional Ordinary Shares under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2019 to 30 June 2019.

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

£16.54

547.914

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

d)

Aggregated information

 

n/a (single transaction)

Aggregated volume Price

 

e)

Date of the transaction

2019-07-24

f)

Place of the transaction

 

n/a

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHQZLFLKDFEBBV
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.